GenSight Biologics Completes Upstream Tech Transfer of LUMEVOQ® Manufacturing to Catalent

Upstream phase of LUMEVOQ® manufacturing process successfully transferred Milestone follows successful manufacture of drug product batch to be u...

June 26, 2025 | Thursday | News
Galapagos Partners with CELLforCURE by SEQENS to Advance Decentralized Manufacturing of CAR T-Cell Therapy in France

CELLforCURE by SEQENS, a leading Contract Development and Manufacturing Organization (CDMO)  specialized in Advanced Therapy Medicinal Products (ATMPs...

June 20, 2025 | Friday | News
Kindeva and Rocket Science Health Partner to Advance Novel Intranasal Delivery Platform Targeting the Olfactory Clefts

Kindeva, a global CDMO and drug delivery expert, and Rocket Science Health (RSH), a Canadian technology healthcare company, have joined forces to find pa...

June 19, 2025 | Thursday | News
Bionova Scientific Installs Third Cytiva FlexFactory to Expand into Genomic Medicines Manufacturing

Third Cytiva FlexFactory manufacturing platform will help the CDMO meet the rising demand for genomic medicines Cytiva’s Fast Trak process devel...

June 19, 2025 | Thursday | News
University of Oxford and ReciBioPharm Expand Collaboration to Manufacture Malaria Vaccine Candidates

  Expands the collaboration to manufacture two malaria vaccine candidates (R78C and RH5.1) for Phase 1/2 clinical trials. Delivers the sixth m...

June 17, 2025 | Tuesday | News
Agenus and Zydus Forge Strategic Partnership to Advance BOT/BAL Immunotherapy and Launch BioCDMO Operations in the U.S.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifescienc...

June 05, 2025 | Thursday | News
Axplora’s Chasse-sur-Rhône Site Achieves Successful ANSM cGMP Inspection Without Remarks

Axplora, a global leader in API small molecule and ADC (antibody-drug conjugate) manufacturing, is proud to announce that its Chasse-sur-Rhône CDMO...

June 04, 2025 | Wednesday | News
Avance Clinical Empowers US Biotechs With GlobalReady Program Amid Regulatory Uncertainty at Home

As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-p...

May 27, 2025 | Tuesday | News
CellFE and Made Scientific Partner to Validate Scalable Non-Viral Gene Editing for T Cell Therapies

CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization...

May 14, 2025 | Wednesday | News
AGC Biologics Joins Hands with South Korea’s Novelty Nobility for Multisite Bispecific Antibody Project

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites AGC Biologics, your friendly CDMO expert, ...

May 06, 2025 | Tuesday | News
Scorpius Holdings Announces Strategic Update Amid Rising CDMO Demand, Eyes Expansion into Southeast Asia

Scorpius Holdings, Inc. (OTC: SCPX), a biomanufacturing company dedicated to advancing therapeutic production capabilities, today announced a comprehensi...

May 05, 2025 | Monday | News
Crown Bioscience Extends Exclusive Partnership with NEXT Oncology to Advance Translational Cancer Research

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corp...

May 02, 2025 | Friday | News
PCI Pharma Services Acquires Ajinomoto Althea to Expand Global Sterile Fill-Finish and ADC Capabilities

Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery...

May 02, 2025 | Friday | News
Meribel Pharma Solutions Launches as Mid-Size European CDMO with 13 Sites Across France, Spain, and Sweden

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network ...

April 15, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close